This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
January 04, 2023
Monica Shaw appointed CEO of Oncopeptides – Jakob Lindberg assumes position as Chief Scientific Officer
December 29, 2022
Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend in Connection with Pending Merger
December 23, 2022
Q3 2022 General Market Overview
December 22, 2022
Targovax announces that the TG01 study in multiple myeloma at Oslo University Hospital has received regulatory approvals to proceed
December 20, 2022
HelloBetter Sleep: First online therapy programme for organic and nonorganic insomnia available on prescription in Germany
December 15, 2022
Marston Forest Healthcare live with Doctrin – the next generation care navigation and online consultation platform
December 15, 2022
Targovax announces clinical trial collaboration with Agenus to test TG mutant RAS vaccination in pancreatic cancer
December 14, 2022
American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema
December 12, 2022
Oncopeptides presents new scientific data at the Annual American Society of Hematology Meeting ASH
December 08, 2022
Vicore has carried out a directed share issue of 10,000,000 shares at a subscription price of SEK 20 per share, raising gross proceeds of SEK 200 million